Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision v3.6.4 was added to the record history and the previous revision v3.6.3 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history now shows the latest revision as v3.6.3, indicating the page was updated. The previous revision v3.6.1 is removed from the history view.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry (v3.6.1) has been added to the Study Record History, superseding the prior revision (v3.6.0). This reflects an updated release of the study record on the ClinicalTrials.gov history page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record now shows that recruitment has ended with a banner stating 'No longer looking for participants'. A new revision tag v3.6.0 was added, replacing the previous v3.5.5.SummaryDifference0.5%

- Check64 days agoChange DetectedThe page shows a newer system revision label (v3.5.5) replacing the previous v3.5.4, indicating an internal update to the study record history interface.SummaryDifference0.1%

- Check78 days agoChange DetectedNew revision v3.5.4 appears in the study's history. The previous revision v3.5.3 is removed from the list.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.